Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin CH0012005267
Ticker NVS
Company NOVARTIS
Currency $
Price
Aware Investor Index (AII) 2.4702
Recommendation BUY
P/E 21.61
ROE 13.04 %
Capitalization 209,169,620,000 $
Dividend Yield 3.25 %
P/S 4.26
AII Position 188
P/E Position 303
ROE Position 271
Capitalization Position 55
Dividend Yield Position 211
Sales 49,109,000,000 $
10-Year Average Earnings 9,680,800,000 $
Shares Outstanding 2,371,000,000
Equity 74,227,000,000 $
Dividend per Share 2.87 $
Industry Pharmaceutical
Country Switzerland
NOVARTIS Investor Relations Web Site http://www.novartis.com/investors/index.shtml







Sales:

YEAR MONTH AMOUNT
2017 12 49,109,000,000.00 $
2016 12 48,518,000,000.00 $
2015 12 49,414,000,000.00 $
2014 12 52,180,000,000.00 $
2013 12 51,869,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 7,703,000,000.00 $
2016 12 6,698,000,000.00 $
2015 12 17,794,000,000.00 $
2014 12 10,280,000,000.00 $
2013 12 9,292,000,000.00 $
2012 12 9,383,000,000.00 $
2011 12 9,072,000,000.00 $
2010 12 9,969,000,000.00 $
2009 12 8,454,000,000.00 $
2008 12 8,163,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 74,227,000,000.00 $
2016 12 74,891,000,000.00 $
2015 12 77,122,000,000.00 $
2014 12 70,884,000,000.00 $
2013 12 74,472,000,000.00 $
2012 12 69,219,000,000.00 $
2011 12 65,940,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 2,371,000,000
2016 12 2,400,000,000
2015 12 2,438,000,000
2014 12 2,470,000,000
2013 12 2,479,000,000
2012 12 2,418,145,330
2011 12 2,406,700,000

 












Bloomberg News for NOVARTIS:



Google News for NOVARTIS:

Wagner Review - 11 hours ago
What's Transpiring With Novartis AG (NYSE:NVS) Shares?
While tracking shares of Novartis AG (NYSE:NVS), we have noted that the current average broker rating is currently 2. Going further, we can ...
Stocks Beat
Novartis (NVS) Announces Promising Data on Tasigna & Hyrimoz
Novartis NVS announced new long-term follow-up data from the ongoing, pivotal open-label ENESTfreedom and ENESTop trials. The data ...
Tech Know Bits
Novartis AG (NVS) Stake Raised by Senator Investment Group Lp ...
Senator Investment Group Lp increased its stake in Novartis A G (NVS) by 66.67% based on its latest 2019Q1 regulatory filing with the SEC.
Rockland Register
Novartis AG (NVS) Holder Senator Investment Group LP Has ...
Senator Investment Group Lp increased its stake in Novartis A G (NVS) by 66.67% based on its latest 2019Q1 regulatory filing with the SEC.
Yahoo Finance - 19 hours ago
Verity & Verity Trimmed Novartis AG (NVS) Position; National ...
Verity & Verity Llc decreased Novartis A G (NVS) stake by 10.9% reported in 2019Q1 SEC filing. Verity & Verity Llc sold 11,804 shares as ...
Stocks Beat - 20 hours ago
Trading Watch: Looking Under the Hood for Novartis AG (NYSE:NVS)
Investors may be taking a closer look at shares of Novartis AG (NYSE:NVS). Sometimes the stock market can be frustrating, even for the most ...
Stocks Beat - 1 day ago
Fayez Sarofim & Company Lowered Its Novartisagsponadr (NVS ...
The stock increased 0.20% or $0.18 during the last trading session, reaching $89.69. About 556,499 shares traded. Novartis AG (NYSE:NVS) ...
Stocks Beat - 1 day ago
This Matters Too Much For Sally Beauty Holdings (SBH), Novartis ...
With the previous 100-day trading volume average of 2.55 million shares, Novartis AG (NVS) recorded a trading volume of 1.89 million shares, ...
Wagner Review - 2 days ago
Novartis (NVS) Announces Various Data Presentations at ASCO
Novartis AG NVS announced few data presentations at the ASCO 2019 annual meeting. The company announced statistically significant ...
Auburn Digest
Novartis AG (NVS) Market Valuation Rose While Reilly Financial ...
Novartis A G (NVS) Market Valuation Rose While Reilly Financial Advisors Boosted Its Position; As Activision Blizzard (ATVI) Stock Rose, ...


Back